심장판막 수복 및 치환 디바이스 시장 : 수술별, 제품별 - 세계 예측(2025-2030년)

The Heart Valve Repair & Replacement Devices Market was valued at USD 6.14 billion in 2023, expected to reach USD 6.64 billion in 2024, and is projected to grow at a CAGR of 8.20%, to USD 10.67 billion by 2030.

The heart valve repair and replacement devices market is defined by products and technologies designed to repair or replace damaged heart valves, primarily targeting mitral and aortic valves. The necessity for these devices stems from rising incidences of heart valve diseases due to aging populations, lifestyle changes, and increasing cardiac dysfunctions worldwide. Applications span from open-heart surgeries to minimally invasive procedures like transcatheter aortic valve replacement (TAVR), which have increased their appeal due to reduced recovery times and surgical risks. Key end-users include hospitals, ambulatory surgical centers, and specialized cardiac clinics. Market growth is significantly influenced by advancements in medical technology, increasing demand for minimally invasive surgeries, and a growing elderly population requiring cardiac care. Economic growth in emerging markets, coupled with expanding healthcare infrastructure, presents new opportunities for device manufacturers. However, high procedural costs, stringent regulatory environments, and complications related to device implantation are key limitations that can impede market progress. Moreover, the COVID-19 pandemic has disrupted supply chains and elective surgeries, impacting market dynamics.

Emerging opportunities lie in the continued development of bio-prosthetic valves, enhanced delivery systems, and the potential integration of AI for better diagnosis and surgical planning. Innovation is best directed towards improving device durability, enhancing valve hemodynamics, and developing scalable training programs for surgical teams. Strategic collaborations for technology transfer, investment in R&D, and keeping abreast of evolving regulatory standards are recommended strategies to capitalize on market growth opportunities. Despite challenges, focusing on personalized medicine and patient-centered innovations could offer competitive advantage. The market's nature is competitive but fragmented, with major players focusing on mergers, acquisitions, and partnerships to strengthen their positions. Emphasis on cost reductions, accommodating reimbursement policies, and proactive patient engagement will be crucial for sustaining growth in this dynamic market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Heart Valve Repair & Replacement Devices Market

The Heart Valve Repair & Replacement Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing availability of advanced computational tools toward accurate diagnosis of valvular disease
  • Surge in the prevalence of cardiovascular diseases globally
  • Increasing number of heart valve repair or replacement surgery
• Market Restraints
  • Relatively expensive device due to extensive manufacturing cost
  • Probability of product recalls
• Market Opportunities
  • Technological advancements with the introduction of biodegradable devices
  • Rapid adoption of transcatheter heart valves globally
• Market Challenges
  • Issues with product approval owing to complex regulatory procedures

Porter's Five Forces: A Strategic Tool for Navigating the Heart Valve Repair & Replacement Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Heart Valve Repair & Replacement Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Heart Valve Repair & Replacement Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Heart Valve Repair & Replacement Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Heart Valve Repair & Replacement Devices Market

A detailed market share analysis in the Heart Valve Repair & Replacement Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Heart Valve Repair & Replacement Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Heart Valve Repair & Replacement Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Heart Valve Repair & Replacement Devices Market

A strategic analysis of the Heart Valve Repair & Replacement Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Heart Valve Repair & Replacement Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aortech International PLC, Artivion, Inc., Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, JenaValve Technology, Inc., LivaNova PLC, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Micro Interventional Devices, NeoChord, Inc., On-X Life Technologies, Pulmonx Corporation, and Valcare Medical.

Market Segmentation & Coverage

This research report categorizes the Heart Valve Repair & Replacement Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Surgery, market is studied across Minimally Invasive Surgeries, Open Surgeries, and Transcatheter Surgeries.
• Based on Product, market is studied across Heart Valve Repair Devices and Heart Valve Replacement Devices. The Heart Valve Replacement Devices is further studied across Mechanical Heart Valve, Tissue Heart Valve, and Transcatheter Heart Valve.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing availability of advanced computational tools toward accurate diagnosis of valvular disease
    • 5.1.1.2. Surge in the prevalence of cardiovascular diseases globally
    • 5.1.1.3. Increasing number of heart valve repair or replacement surgery
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively expensive device due to extensive manufacturing cost
    • 5.1.2.2. Probability of product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements with the introduction of biodegradable devices
    • 5.1.3.2. Rapid adoption of transcatheter heart valves globally
  • 5.1.4. Challenges
    • 5.1.4.1. Issues with product approval owing to complex regulatory procedures
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Heart Valve Repair & Replacement Devices Market, by Surgery

• 6.1. Introduction
• 6.2. Minimally Invasive Surgeries
• 6.3. Open Surgeries
• 6.4. Transcatheter Surgeries

7. Heart Valve Repair & Replacement Devices Market, by Product

• 7.1. Introduction
• 7.2. Heart Valve Repair Devices
• 7.3. Heart Valve Replacement Devices
  • 7.3.1. Mechanical Heart Valve
  • 7.3.2. Tissue Heart Valve
  • 7.3.3. Transcatheter Heart Valve

8. Americas Heart Valve Repair & Replacement Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Heart Valve Repair & Replacement Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Heart Valve Repair & Replacement Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aortech International PLC
• 3. Artivion, Inc.
• 4. Boston Scientific Corporation
• 5. CryoLife, Inc.
• 6. Edward Lifesciences Corporation
• 7. JenaValve Technology, Inc.
• 8. LivaNova PLC
• 9. Medtronic PLC
• 10. Meril Life Sciences Pvt. Ltd.
• 11. Micro Interventional Devices
• 12. NeoChord, Inc.
• 13. On-X Life Technologies
• 14. Pulmonx Corporation
• 15. Valcare Medical